124 related articles for article (PubMed ID: 6750020)
1. Determination of anti-malignin antibody and malignin in 1,026 cancer patients and controls: relation of antibody to survival.
Bogoch S; Bogoch ES; Fager CA; Harris JH; Ambrus JL; Lux WE; Ransohoff JA
J Med; 1982; 13(1-2):49-69. PubMed ID: 6750020
[No Abstract] [Full Text] [Related]
2. Early detection and monitoring of cancer with the anti-malignin antibody test.
Abrams MB; Bednarek KT; Bogoch S; Bogoch ES; Dardik HJ; Dowden R; Fox SC; Goins EE; Goodfried G; Herrman RA
Cancer Detect Prev; 1994; 18(1):65-78. PubMed ID: 8162608
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of immune complexes, associated antigen, and antibody in cancer.
Salinas FA; Wee KH; Silver HK
Contemp Top Immunobiol; 1985; 15():55-109. PubMed ID: 3896644
[No Abstract] [Full Text] [Related]
4. Radiodiagnostic and radiotherapeutic implications of the recent discovery of a common malignant tumour antigen, CTA, absolutely unique to cancer cells.
Kast RE
Radiobiol Radiother (Berl); 1977; 18(4):536-44. PubMed ID: 601218
[No Abstract] [Full Text] [Related]
5. Anti-malignin antibody evaluation: a possible challenge for cancer management.
Botti C; Martinetti A; Nerini-Molteni S; Ferrari L
Int J Biol Markers; 1997; 12(4):141-7. PubMed ID: 9582602
[TBL] [Abstract][Full Text] [Related]
6. Introduction: methodology for detection of antigens in preneoplastic and neoplastic tissues.
Borsos T
Natl Cancer Inst Monogr; 1972 Dec; 35():3-4. PubMed ID: 4659053
[No Abstract] [Full Text] [Related]
7. Astrocytin and malignin: two polypeptide fragments (recognins) related to brain tumor.
Bogoch S
Natl Cancer Inst Monogr; 1977 Dec; 46():133-7. PubMed ID: 613224
[No Abstract] [Full Text] [Related]
8. Anti-neuronal antibodies in patients with cancer.
Posner JB
Ann Neurol; 2004 Nov; 56(5):609-10. PubMed ID: 15505822
[No Abstract] [Full Text] [Related]
9. [Immunology in the early diagnosis of gastrointestinal cancer].
Meeroff M
Acta Gastroenterol Latinoam; 1972; 4(2):75-83. PubMed ID: 4581895
[No Abstract] [Full Text] [Related]
10. In vitro production of the general transformation antibody related to survival in human cancer patients: antimalignin antibody.
Bogoch S; Bogoch ES; Iliescu VM
Cancer Detect Prev; 1988; 12(1-6):313-20. PubMed ID: 3180136
[TBL] [Abstract][Full Text] [Related]
11. Tumor markers: malignin and related recognins associated with malignancy rather than with cell type.
Bogoch S; Bogoch ES
Prog Clin Biol Res; 1980; 39():407-24. PubMed ID: 7403189
[No Abstract] [Full Text] [Related]
12. Malignin antibody and early malignancy.
Bogoch S; Bogoch ES
Lancet; 1991 Apr; 337(8747):977. PubMed ID: 1678055
[No Abstract] [Full Text] [Related]
13. Basic principles of the immune response and the immunologic inhibition of tumors.
Vorlaender KO
Allergol Immunopathol (Madr); 1973 Jul; 1(4):235-46. PubMed ID: 4794103
[No Abstract] [Full Text] [Related]
14. [1st immunologic attempts in the treatment of human malignant tumors].
Mannelli MA
Minerva Med; 1977 Apr; 68(19):1301-4. PubMed ID: 854230
[No Abstract] [Full Text] [Related]
15. [Laboratory tests in the diagnosis of cancer. Biological markers of cancer].
Senra Varela A; Palmeiro Troitiño R; Millán Núñez-Cortés J; García-Blanco Saceda P
Rev Clin Esp; 1982 Jul 15-31; 166(1-2):1-6. PubMed ID: 7146512
[No Abstract] [Full Text] [Related]
16. Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity.
Goodell V; Disis ML
J Immunol Methods; 2005 Apr; 299(1-2):129-38. PubMed ID: 15914197
[TBL] [Abstract][Full Text] [Related]
17. Disarmed anti-malignin antibody in human cancer.
Bogoch S; Bogoch ES
Lancet; 1979 May; 1(8123):987. PubMed ID: 87667
[No Abstract] [Full Text] [Related]
18. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection.
Megliorino R; Shi FD; Peng XX; Wang X; Chan EK; Tan EM; Zhang JY
Cancer Detect Prev; 2005; 29(3):241-8. PubMed ID: 15896923
[TBL] [Abstract][Full Text] [Related]
19. A checklist for suitability of biomarkers as surrogate endpoints in chemoprevention of breast cancer.
Bogoch S; Bogoch ES
J Cell Biochem Suppl; 1994; 19():173-85. PubMed ID: 7823589
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of cell surface antigens for antibody targeting in oncology.
Carter P; Smith L; Ryan M
Endocr Relat Cancer; 2004 Dec; 11(4):659-87. PubMed ID: 15613445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
